Urinary proteome analysis enables assessment of renoprotective treatment in type 2 diabetic patients with microalbuminuria
about
Proteomics for prediction of disease progression and response to therapy in diabetic kidney diseaseEvaluation of the Zucker diabetic fatty (ZDF) rat as a model for human disease based on urinary peptidomic profilesCE-MS for the analysis of intact proteins 2010-2012.Prediabetic nephropathy as an early consequence of the high-calorie/high-fat diet: relation to oxidative stress.Role of IGFBP7 in Diabetic Nephropathy: TGF-β1 Induces IGFBP7 via Smad2/4 in Human Renal Proximal Tubular Epithelial Cells.Differential urinary glycoproteome analysis of type 2 diabetic nephropathy using 2D-LC-MS/MS and iTRAQ quantification.Urinary proteomics for early diagnosis in diabetic nephropathy.Identification of urinary proteins potentially associated with diabetic kidney disease.Clinical proteomic biomarkers: relevant issues on study design & technical considerations in biomarker development.Proteomics in chronic kidney disease: The issues clinical nephrologists need an answer for.Urine proteomics in kidney and urogenital diseases: Moving towards clinical applications.Recent advances in capillary electrophoresis coupled to mass spectrometry for clinical proteomic applications.Clinical applications of capillary electrophoresis coupled to mass spectrometry in biomarker discovery: Focus on Bladder Cancer.Proteomic urinary biomarker approach in renal disease: from discovery to implementation.Capillary zone electrophoresis on-line coupled to mass spectrometry: A perspective application for clinical proteomics.Proteomic biomarkers in kidney disease: issues in development and implementation.Body fluid peptide and protein signatures in diabetic kidney diseases.Prognostic clinical and molecular biomarkers of renal disease in type 2 diabetes.Implementation of CE-MS-identified proteome-based biomarker panels in drug development and patient management.Urinary Proteomics for Diagnosis and Monitoring of Diabetic Nephropathy.The long path towards implementation of clinical proteomics: Exemplified based on CKD273.Noninvasive diagnosis of chronic kidney diseases using urinary proteome analysis.Urinary peptide-based classifier CKD273: towards clinical application in chronic kidney disease.Pro: urine proteomics as a liquid kidney biopsy: no more kidney punctures!A urinary peptide biomarker set predicts worsening of albuminuria in type 2 diabetes mellitus.The effect of sodium/glucose cotransporter 2 (SGLT2) inhibition on the urinary proteome.Urinary peptidomics in kidney disease and drug research.Predicting albuminuria response to spironolactone treatment with urinary proteomics in patients with type 2 diabetes and hypertension.Urinary proteomics for prediction of mortality in patients with type 2 diabetes and microalbuminuria.Novel Urinary Biomarkers For Improved Prediction Of Progressive Egfr Loss In Early Chronic Kidney Disease Stages And In High Risk Individuals Without Chronic Kidney Disease
P2860
Q26747131-0579B2B1-58E6-45F7-BF0F-A568E36D1D63Q28484239-3565E80E-0207-4A62-AA57-90BDC5174222Q34480662-39E363A7-8F58-41E8-99AB-936C9219B7ACQ35762675-E7A3F2C1-1173-4F0F-A51C-210C69A5B6EEQ35956447-6E3A80DB-AD58-460C-BBF0-1BDC6F15EFBBQ36321624-8AB66C33-7BCC-4F5C-944F-6A869FAD0477Q36410737-AA3AD5C9-9971-4E61-AEA8-8B7F4EE4F484Q37460323-96C893B0-CFCC-46C0-84F7-23737DBF523FQ37714579-6D1C3375-232A-45FF-A1EA-1F0EFC655FACQ37871572-E3BE6853-9CCF-4261-BBE8-7F5250664A9BQ37876853-7EF02E15-A5E8-4EEC-88FF-414FF9DBEB91Q38091336-915C5F85-0DA7-4438-B97E-DACD7A1E88A1Q38130892-0C1FB8F2-EC27-4D10-AE05-A9F8B7D67D88Q38196316-10BA9AEC-E397-45BE-B8BE-C88194030162Q38340351-40EA1DC6-DFF0-49F7-8BB5-028910C15134Q38341211-56C45508-F097-4CD2-A738-CC380C8B81D6Q38553924-D6D97F45-DECD-4609-9008-2FA215B10D8FQ38553932-69F87A82-F827-4B79-A83D-884691072CAAQ38906256-95D7DD84-546D-4586-8BBE-F7FBF3293BF4Q38961899-3DCA819E-ACC0-41D1-9ADE-8E508B7821C9Q39055330-F241B24C-908A-4D71-A5B2-46BB8A9703A5Q39094572-B833F0DC-B230-4398-9B67-4A3333C41491Q39427234-62A44F1D-9541-4D51-A712-211C82698CE3Q41173762-0DAE9EFE-5AC9-4621-8E18-D7C0BDE1CB85Q44319128-44F2DE3A-B748-46CA-B587-5A04F32DB3F0Q47587893-7ACFD154-A425-4685-94DD-658F597023C1Q47781932-767F2611-5B6D-45B6-A2CC-790D22C0E0D2Q53536253-D4229801-ABF5-4546-AA27-05E3FABEC41AQ55112495-A4E63FB6-222E-4123-A957-8629FD4B6BEFQ58107393-98A546C7-2D75-4E72-A14F-A0A43EF1B903
P2860
Urinary proteome analysis enables assessment of renoprotective treatment in type 2 diabetic patients with microalbuminuria
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Urinary proteome analysis enab ...... patients with microalbuminuria
@ast
Urinary proteome analysis enab ...... patients with microalbuminuria
@en
type
label
Urinary proteome analysis enab ...... patients with microalbuminuria
@ast
Urinary proteome analysis enab ...... patients with microalbuminuria
@en
prefLabel
Urinary proteome analysis enab ...... patients with microalbuminuria
@ast
Urinary proteome analysis enab ...... patients with microalbuminuria
@en
P2860
P50
P356
P1433
P1476
Urinary proteome analysis enab ...... patients with microalbuminuria
@en
P2093
Hans-Henrik Parving
P2860
P2888
P356
10.1186/1471-2369-11-29
P577
2010-11-01T00:00:00Z
P5875
P6179
1010356073